ADULT SOLID TUMOR
Clinical trials for ADULT SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new ADULT SOLID TUMOR trials appear
Sign up with your email to follow new studies for ADULT SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First patients to receive experimental cancer drug in groundbreaking safety trial
Disease control Recruiting nowThis is the first-ever study in people to test a new cancer drug called TT125-802. The main goal is to find a safe dose and check for side effects in 50 adults with advanced solid tumors that have stopped responding to standard treatments. Researchers will also look for early sig…
Matched conditions: ADULT SOLID TUMOR
Phase: PHASE1 • Sponsor: TOLREMO therapeutics AG • Aim: Disease control
Last updated Apr 01, 2026 20:11 UTC
-
New hope for lung cancer patients: experimental drug trial seeks to boost standard treatment
Disease control Recruiting nowThis trial is testing whether adding an experimental drug called visugromab to standard first-line treatment helps people with newly diagnosed, advanced non-squamous lung cancer. About 107 participants will be randomly assigned to receive either the new combination or the standar…
Matched conditions: ADULT SOLID TUMOR
Phase: PHASE2 • Sponsor: CatalYm GmbH • Aim: Disease control
Last updated Mar 23, 2026 15:28 UTC
-
New antibody joins fight against tough lung cancers
Disease control Recruiting nowThis study is testing whether adding a new antibody drug called visugromab to standard treatments helps control advanced non-small cell lung cancer that has worsened after initial therapy. It will compare different combinations of visugromab, an immunotherapy drug (nivolumab), an…
Matched conditions: ADULT SOLID TUMOR
Phase: PHASE2 • Sponsor: CatalYm GmbH • Aim: Disease control
Last updated Feb 23, 2026 14:56 UTC